Related Experiment Video
Updated: Mar 25, 2026

08:54
Author Spotlight: Understanding Age-Related Macular Degeneration Pathophysiology with QAF Workflow
Published on: May 26, 2023
2.3K
VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION
Arthika Chandramohan1, Sandra S Stinnett, John T Petrowski
1Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina.
Retina (Philadelphia, Pa.)
|March 2, 2016
Summary
Computerized low luminance visual acuity (LLVA) and Cone Contrast Test (CCT) are feasible and repeatable for assessing dry age-related macular degeneration (AMD). These tests show promise as clinical trial endpoints for monitoring disease progression.
Area of Science:
- Ophthalmology
- Vision Science
- Clinical Research
Background:
- Dry age-related macular degeneration (AMD) is a leading cause of vision loss.
- Assessing visual function in early dry AMD is crucial for clinical trials and patient management.
- Current methods may not fully capture the subtle visual deficits in early stages of the disease.
Purpose of the Study:
- To evaluate the feasibility of computerized tests for low luminance visual acuity (LLVA), Cone Contrast Test (CCT), contrast sensitivity, and microperimetry in dry AMD patients.
- To assess the test-retest repeatability of these visual function metrics in individuals with dry AMD.
Main Methods:
- A prospective pilot study involving 30 participants (8 controls, 8 early AMD, 12 intermediate AMD).
- Subjects underwent testing for LLVA, contrast sensitivity, CCT, and microperimetry with eye tracking.
- Follow-up testing was conducted after approximately one month to assess repeatability.
Main Results:
- High test-retest repeatability (intraclass correlations >0.7) was observed for LLVA, CCT, and microperimetry.
- Intermediate AMD patients showed significant deficits in best-corrected visual acuity, LLVA, low luminance deficit, and red CCT compared to controls.
- Contrast sensitivity and green/blue CCT did not show significant differences between intermediate AMD patients and controls.
Conclusions:
- Computerized LLVA, microperimetry, and CCT are feasible and reliable tools for evaluating visual function in early dry AMD.
- These measures demonstrate potential as alternative endpoints for future clinical trials in dry AMD.
- Further investigation in a larger natural history study is recommended to validate these findings.

